Puma Biotechnology, Inc.

PBYI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2014 Mar 2014 Dec 2013 Sep 2013 Jun 2013 Mar 2013 Dec 2012 Sep 2012
Operating Activities
Net Income $-38.8M $-19.8M $-15.9M $-14.3M $-12.7M $-11.8M $-21.9M $-25.9M
Depreciation & Amortization $146.0K $133.0K $125.0K $109.0K $99.0K $90.0K $77.7K $68.8K
Depreciation — — — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation $7.2M $5.2M $3.1M $1.8M $1.4M $1.2M $18.8M $358.0K
Net Cash from Operating Activities $17.4M $-17.0M $-13.6M $-12.0M $-11.0M $-18.5M $-24.8M $-7.6M
Investing Activities
Capital Expenditures — — — — — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities — — $3.3M $2.2M $-19.8M $-27.3M $-389.0K $-11.0K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities — — — — — — — —
Net Change in Cash $-108.0M $120.3M $-8.2M $-9.6M $-30.7M $-45.8M $104.1M $-7.7M
Free Cash Flow — — — — — — — —
← Newer Page 7 of 8 Older →